iCARE Herpes-2 IgG Rapid Test Kit

Detection of HSV-2 IgG/IgM Antibodies in Human Serum or Plasma

This test is intended for screening patients with suspected herpes infection. It detects antibodies to the HSV-2 IgG/IgM antigen in human serum or plasma. It cannot determine the site of infection, as the two strains of the virus are highly cross-reactive.

The iCARE Herpes-2 IgM Rapid Test Kit detects HSV-2 IGG/IgM antibodies in human serum and plasma. This test is an important diagnostic tool for the diagnosis of herpes infection. The results of this test should be reported within 2 to 4 weeks.

Serological tests can detect antibodies to DENV, HSV-2, and CHIKV. These tests are most accurate when the IgG/IgM antibody concentration is >70 mg/ml.

The test is accurate and highly sensitive, with a sensitivity of 100% and 98% specificity. It is a convenient and quick test for clinical use. It can be carried from one lab to another, and results can be obtained in 10 minutes. It is also highly portable, with a storage time of up to 24 months.

This test is a highly sensitive HSV-2 IgG/IgG rapid test kit that detects HSV-2 IgG/M antibodies in human serum or plasma. This test is ideal for detecting acute herpes infection in immunocompromised patients. This test is also useful for chronic HSV infection.

iCare Herpes Simplex Virus 2 IgG Rapid Test Kit

Detection of CHIKV/CHIKV IgM/IgG Antibodies in Human Serum or Plasma

Detection of CHIKV IgM/Igg antibodies in human serum or plasma is a sensitive and specific test for the diagnosis of CHIKV. The IC test is a rapid test that identifies antibodies by reacting to the E1 proteins of CHIKV. It shows high sensitivity and can detect CHIKV, other alphaviruses, and non-alphaviruses. Detection of serum IgM and IgG antibodies is available up to several months after the onset of symptoms. However, IgG antibodies can persist for years after the infection.

Although CHIKV infection is rarely fatal, it can cause significant neurological and joint sequelae. Most patients will experience symptoms within two weeks, but a significant proportion of patients can develop chronic illness lasting months or even years. In these patients, detection of anti-CHIKV IgM/IgG antibodies in serum or plasma can indicate whether the patient has an active infection and whether the infection is causing symptoms or not.

Detection of CHIKV IgM/IgM/IgG antibodies in human sera or plasma is a useful tool to detect the presence of chikungunya virus infection in patients with a history of travel or other arthropod-borne infections. However, the sensitivity and specificity of this test is not as high as that of the Inbios test, which has the highest specificity.

Detection of CHIKV IgM/IgM antibodies in human serum or plasma is a rapid, qualitative test that is widely available and inexpensive. It provides a rapid and reliable diagnosis of the disease. It is an ideal tool for outbreak control in areas with limited access to laboratories.